Inhalational Agents Flashcards

1
Q

What are some terms for inhalational agents?

A

Anaesthetic gases, anaesthetic agents, volatiles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What affects the uptake and distribution of volatile agents?

A

(1) DELIVERY of the agent to the lungs
(2) UPTAKE of the agent from the lungs to the bloodstream
(3) UPTAKE of the agent into other tissues (besides the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What governs the partial pressures of anaesthetic in all body tissues?

A

The alveolar partial pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the relationship between alveolar concentration of an agent and alveolar partial pressure?

A

Direct proportionality.
Factors decreasing alveolar concentration slow down induction of anaesthesia,
and vice versa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Relationship between ability to dissolve in blood and induction? Provide a reason.

A

Agent that dissolves easily=slow induction
Agent that is insoluble in blood=faster induction
If insoluble in blood–> fat soluble, like the brain tissue. Thus, agent is ready to bind to the fatty tissue in the brain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Relationship between the cardiac output and rate of induction? Provide a reason.

A

Faster cardiac output= slower rate of induction.
Blood needs enough time to travel through the capillary/alveolar interface to pick up enough agent… if the cardiac output is higher, blood will not be as saturated with agent
SHUNTING (blood passing through alveoli that are not ventilated) will adversely affect induction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List the factors that leads to a faster induction of an agent

A
High inspired concentration of agent
Increased ventilation
Less soluble agent (in blood)
Decreased cardiac output
Decreased shunting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List the factors that leads to a slower induction of an agent

A
Lower inspired concentration of agent
Decreased ventilation
More soluble agent (in blood)
Increased cardiac output
Increased shunting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does solubility affect recovery from anaesthesia?

A

Recovery is slow from soluble agents e.g. halothane.

Recovery is fast from poorly soluble agents eg desflurane and sevoflurane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Harmful metabolites from volatile agents

A

CF3 group causes “Halothane Hepatitis”
Fluorides from older agents like methoxyflurane and enflurane renal impairment
“Compound A” from Sevoflurane (renal impairment in rats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Explain potency of volatiles

A

Potency is the measure of a drug’s efficacy at a given dose
A more potent agent requires a lower dose to achieve the same effect; a less potent drug requires more
The concept of MAC is a measure of volatile potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does MAC stand for and how does it relate to potency of a volatile agent?

A

MAC (%): Minimum Alveolar Concentration (in %) required to prevent 50% of patients from moving in response to a standard surgical stimulus (incision) at sea level.
Hence a low MAC = more potent (e.g. Halothane = 0.75%) and a high MAC – less potent (e.g desflurane =6 %)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which factors leads to a decrease in the MAC?

A
Sedatives 
N2O 
Analgesics 
Increased age 
hypotension 
hypothermia 
myxoedema 
Less effect: hypoxia, anaemia, pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which factors leads to an increase in the MAC

A

Alcoholism
Increased in children
Hyperthermia
Thyrotoxicosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What colour is nitrous oxide?

A

Blue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MAC of nitrous oxide

A

105%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Nitrous oxide- CNS effects

A

Potent analgesic
Poor anaesthetic
> 80% = hypoxic gas mix, always give max 70%
Second gas effect (need less [AA]) and speeds up induction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Nitrous oxide- CVS effects

A

Negative inotrope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Nitrous oxide- Resp effects

A

Augment depression of other agents

Diffusional hypoxia – after switch off NO2 from blood diffuse into alveoli and displace O2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Nitrous oxide- Muscle effects

A

no MH trigger

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Nitrous oxide- additional info

A

Only ‘gas’ – stored as liquid.
Flow meter control

Diffuses into air filled cavities = rapid expansion (think pneumothorax and middle ear)

22
Q

Colour and MAC of sevoflurane

A

Yellow

2%

23
Q

sevoflurane- CNS Effects

A

Low sol = fast induction
Slight incr. CBF and ICP (Monroe Kelly doctrine)
Decr O2 consump

24
Q

sevoflurane- CVS Effects

A
Mild -ve inotrope
Slight BP drop
No HR compensate = CO not maint
Prolong qT 
No dysrhythm
25
Q

sevoflurane- Resp Effects

A

Dose dependant depression

26
Q

sevoflurane- Muscle Effects

A

Adequate relaxtion for intubation w children

Rigidity on induction

27
Q

sevoflurane Additional Information

A
Sweet smelling
Best gas induction
*ideal for cardiac pt
Caution renal pt (compound A and floride)
Possible emergence delirium
28
Q

Colour and MAC of Isoflurane

A

Purple

1.14-1.2%

29
Q

Isoflurane- CNS effects

A

ICP stable
Decr cerebral met rate/O2 consumption
Decr CSF prod
*ideal neurosurgery

30
Q

Isoflurane- CVS Effects

A

Min depression
Peripheral vasodilate = decr BP
Pulse maintained

31
Q

Isoflurane- Resp effects

A

Irritant to airway

Not suitable for induction

32
Q

Isoflurane- Muscle effects

A

Relax.
Potentiates NDMRs
Relax uterus

33
Q

Isoflurane- Liver toxicity

A

Low toxicity potential

Isolated enzyme elevations

34
Q

Isoflurane- Additional Information

A

Halogenated ether
Good eye op condition
*ideal for liver pt

35
Q

Colour and MAC of Halothane

A

Red

0.75%

36
Q

Halothane- CNS effects

A

Potent anaesthetic

Incr. CBF and ICP (min by hyperventilation)

37
Q

Halothane- CVS Effects

A

Depressant Hypotension via vasodilate

Dysrhythmias – dose related

38
Q

Halothane- Resp effects

A

Depressant (dose related)

Increase RR but decr tidal vol

39
Q

Halothane- Muscle Effects

A

Some relaxation

Decr. uterine tone (risk C/S)

40
Q

Halothane- Liver toxicity

A

Mild incr. in enzymes

41
Q

Halothane- Additional Information

A

Decomposed by light
Incr sol, slow induction
Rare halothane hepatitis

42
Q

Colour and MAC of Desflurane

A

Sky blue

6%

43
Q

Desflurane- CNS Effects

A

CNS stable

insoluble = rapid induction and emergence

44
Q

Desflurane- CVS Effects

A

Min depression

45
Q

Desflurane- Resp Effects

A

Irritant - Not suited for induction

46
Q

Desflurane- Muscle Effects

A

Some relax

47
Q

Desflurane- Liver toxicity

A

Toxic carbon monoxide - exposed to dry soda lime

48
Q

Desflurane- Additional Information

A

Special vaporizer (BP close to room temp

49
Q

Malignant hyperthermia and its triggers.

A

• Acute hypermetabolic state within muscle tissue during induction of GA (defect in muscle Ca receptor – calcium stays in cells) = increase in metabolic rate, CO2 and O2 consumption. Sympathetic activation (increase CO by incr HR and vasodilate)
Triggers- All inhalational agents and suxamethonium

50
Q

How to recognise malignant hyperthermia

A

Early: muscle rigidity

b. High temp is a LATE sign
c. Blood gas will show: metabolic/resp ACIDOSIS = +++ K/Ca/creatinine kinase
d. Myoglobinuria and acute renal failure
e. ECG changes: hyperkalaemia (peaked T wave, widened QRS, flat P) can lead to VF

51
Q

Immediate Mx for malignant hyperthermia

A

a. STOP all triggering agents
b. Call for HELP (get antidote = DANTROLENE)
c. Change to clean breathing system and hyperventilate pt (elimination of AA)
d. Maintain anaesthesia w IV agent
e. Abandon/finish surgery ASAP

52
Q

Mx and monitoring for malignant hyperthermia

A

a. Give dantrolene (2.5mg/kg bolus, repeat 1mg/kg as needed to max 10mg/kg)
b. Initiate active cooling (antipyretics not useful) & avoid vasoconstriction
c. Treat: hyperkalaemia (CaCl), arrhythmias (Mg/amiodarone, avoid Ca channel blockers), metabolic acidosis (hyperventilate), myoglobinaemia (forced alkaline diuresis), FIC (FFP, cryoprecipitate, platelets)
d. Check plasma CK ASAP
e. Admit ICU, monitor renal fxn, repeat CK, look at alt dx, counsel pt and fam (genetic factors)